Publications by authors named "Georg Golor"

Claim this Profile
M
Multiple-dose clinical pharmacology of the selective orexin-1 receptor antagonist ACT-539313.
Priska Kaufmann, Marion Ort, Georg Golor, Rüdiger Kornberger, Jasper Dingemanse

Prog Neuropsychopharmacol Biol Psychiatry· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmacokinetics of Roxadustat After Concomitant or Time-separated Administration in Healthy Individuals.
Dorien Groenendaal-van de Meent, Virginie Kerbusch, Begona Barroso-Fernandez, Martin den Adel, Jan van Dijk, Georg Golor

Clin Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased sphingosine-1 phosphate receptor-1 agonist for endothelial protection.
Luc Bergougnan, Sara Armani, Georg Golor, Agnes Tardat, Olivier Vitse

Br J Clin Pharmacol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human study with ACT-539313, a novel selective orexin-1 receptor antagonist.
Priska Kaufmann, Marion Ort, Georg Golor, Rüdiger Kornberger, Jasper Dingemanse

Br J Clin Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.
Niels-Peter Becker, Annekathrin Haberland, Katrin Wenzel, Peter Göttel, Gerd Wallukat, Georg Golor

Clin Drug Investig· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes.
Charlotte Granhall, Morten Donsmark, Thalia M Blicher, Georg Golor, Flemming L Søndergaard

Clin Pharmacokinet· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects.
Dorien Groenendaal-van de Meent, Martin den Adel, Jan van Dijk, Begona Barroso-Fernandez, Rachid El Galta, Georg Golor

Eur J Drug Metab Pharmacokinet· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects.
Peter D van der Ark, Georg Golor, Luc van Nueten, Partha Nandy, Peter de Boer

J Psychopharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects.
Uwe Schuehly, Surya Ayalasomayajula, Jeppe Buchbjerg, Parasar Pal, Georg Golor

Eur J Clin Pharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects.
Valentin Demmel, Anne Sandberg-Schaal, Jacob B Jacobsen, Georg Golor, Jonas Pettersson

Diabetes Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.
Helene Hausner, Julie Derving Karsbøl, Anders G Holst, Jacob B Jacobsen, Frank-Dietrich Wagner, Georg Golor

Clin Pharmacokinet· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hypoxia-inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat (FG-4592) and Warfarin in Healthy Volunteers: A Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction Study.
Dorien Groenendaal-van de Meent, Martin den Adel, Sanne Rijnders, Axel Krebs-Brown, Virginie Kerbusch, Georg Golor

Clin Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects.
Reinhard H A Becker, Jens Stechl, Axel Steinstraesser, Georg Golor, Franck Pellissier

Diabetes Metab Res Rev· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of olokizumab, an anti-IL-6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study.
Kosmas Kretsos, Georg Golor, Astrid Jullion, Matthew Hickling, Suzanne McCabe

Clin Pharmacol Drug Dev· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study.
Astrid Breitschaft, Ke Hu, Karina Hermosillo Reséndiz, Christelle Darstein, Georg Golor

Diabetes Res Clin Pract· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers.
Georg Golor, Ke Hu, Matthieu Ruffin, Alexandra Buchelt, Emmanuel Bouillaud

Drug Des Devel Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of yogurt and applesauce on the oral bioavailability of nilotinib in healthy volunteers.
Ophelia Q P Yin, Marc Rudoltz, Ivana Galetic, Jeiry Filian, Arun Krishna, Georg Golor

J Clin Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of nilotinib on single-dose warfarin pharmacokinetics and pharmacodynamics: a randomized, single-blind, two-period crossover study in healthy subjects.
Ophelia Q P Yin, Neil Gallagher, Deirdre Fischer, Lily Zhao, Wei Zhou, Georg Golor

Clin Drug Investig· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the proton pump inhibitor esomeprazole on the oral absorption and pharmacokinetics of nilotinib.
Ophelia Q P Yin, Neil Gallagher, Deirdre Fischer, Eren Demirhan, Wei Zhou, Georg Golor

J Clin Pharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.
Marta Robert, Miquel Salvà, Rosa Segarra, Marco Pavesi, Ramón Esbri, Georg Golor

Drug Metab Dispos· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study.
Wolfgang Uhl, Arno Nolting, Georg Golor, Karl Ludwig Rost, Andreas Kovar

Clin Toxicol (Phila)· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide.
Birgitte Damholt, Georg Golor, Werner Wierich, Poul Pedersen, Marianne Ekblom

J Clin Pharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics of alamifovir and its metabolites.
Clark Chan, Eyas Abu-Raddad, Georg Golor, Hikari Watanabe, Akira Sasaki

Antimicrob Agents Chemother· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of food on everolimus absorption: quantification in healthy subjects and a confirmatory screening in patients with renal transplants.
John M Kovarik, Stefan Hartmann, Joaquim Figueiredo, Christiane Rordorf, Georg Golor

Pharmacotherapy· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue concentrations and induction of a hepatic monooxygenase in male Wistar rats after repeated doses of defined polychlorinated dibenzo-p-dioxin and dibenzofuran (PCDDs and PCDFs) mixtures.
Wolfgang Körner, Georg Golor, Thomas Schulz, Thomas Wiesmüller, Hanspaul Hagenmaier

Arch Toxicol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis